(0.10%) 5 522.25 points
(0.12%) 39 892 points
(0.21%) 19 793 points
(-0.01%) $81.62
(0.60%) $2.83
(-0.32%) $2 337.00
(-0.03%) $29.52
(0.21%) $1 003.90
(0.00%) $0.931
(-0.03%) $10.53
(0.00%) $0.788
(-0.85%) $87.25
-2.63% $ 1.850
Live Chart Being Loaded With Signals
Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company\'s pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia...
Stats | |
---|---|
Dzisiejszy wolumen | 3 109 |
Średni wolumen | 12 369 |
Kapitalizacja rynkowa | 10.98M |
EPS | $-0.910 ( Q1 | 2024-05-09 ) |
Następna data zysków | ( $0 ) 2024-08-07 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.400 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0400 (2.15%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-11 | Wool Kyle Michael | Buy | 154 559 | Common Stock |
2024-06-11 | Hayes Anthony | Buy | 154 559 | Common Stock |
2024-05-30 | Hayes Anthony | Buy | 3 482 | Common Stock |
2024-05-29 | Hayes Anthony | Buy | 1 158 | Common Stock |
2024-05-29 | Wool Kyle Michael | Buy | 5 000 | Common Stock |
INSIDER POWER |
---|
100.00 |
Last 63 transactions |
Buy: 1 831 956 | Sell: 0 |
Dominari Holdings Inc. Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Dominari Holdings Inc. Finanse
Annual | 2023 |
Przychody: | $2.04M |
Zysk brutto: | $1.60M (78.32 %) |
EPS: | $-4.38 |
FY | 2023 |
Przychody: | $2.04M |
Zysk brutto: | $1.60M (78.32 %) |
EPS: | $-4.38 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $188 000 (0.00 %) |
EPS: | $-7.23 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-1.530 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Dominari Holdings Inc.
Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company\'s pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as AIkido Pharma Inc. and changed its name to Dominari Holdings Inc. in December 2022. Dominari Holdings Inc. was founded in 1967 and is headquartered in New York, New York.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej